The latest study on the AI in Cancer Diagnosis and Therapy Market industry includes a detailed analysis of the future trends and demands for the forecast period, 2020 – 2030 . The report covers the estimation of key market players, emerging new players, and regional analysis to offer a better understanding of the AI in Cancer Diagnosis and Therapy Market . Furthermore, the report is updated with the changes in the market dynamics and economic scenario due to the COVID-19 pandemic. The report assesses the impact of the pandemic on the overall market and provides a detailed assessment of the present and future impact of the COVID-19 pandemic on the industry.
The global Artificial Intelligence (AI) in cancer diagnosis & therapy market size was USD 367.9 Million in 2021 and is expected to register a revenue CAGR of 34.4% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer in global population and rising mortality rate from cancer are expected to drive revenue growth of the global AI in cancer diagnosis & therapy market. In addition, significant developments in AI-based approaches to detect genetic changes and aberrant protein interactions at an early stage are driving market revenue growth.
Key participants include Pfizer Inc., Therapixel, SOPHiA Genetics, Janssen Global Services, LLC., PathAI, IBM, Microsoft, Oracle, OncoHealth, and Oncora Medical.
To know more about AI in Cancer Diagnosis and Therapy Market report, visit @ https://www.emergenresearch.com/industry-report/artificial-intelligence-in-cancer-diagnosis-and-therapy-market
Covid 19 analysis:
the report is attuned with the latest market changes and economic landscape with regard to the currently unfolding COVID-19 pandemic. . The pandemic has dynamically affected all aspects of life on a global scale along with drastic changes in the economy and market conditions. The report covers the currently fluctuating market scenario along with present and future assessment of the COVID-19 impact. The report encompasses the historical data, company overview, financial standing, and necessary information about the new and key players of the market.
Emergen Research has segmented the global AI in cancer diagnosis & therapy market based on surgery type, cancer type, end-use, and region:
Surgery Type Outlook (Revenue, USD Million; 2019-2030)
Radiotherapy
Chemotherapy
Immunotherapy
Precision Therapy
Phototherapy
Gene Therapy
Sonodynamic Therapy
Cancer Type Outlook (Revenue, USD Million; 2019-2030)
Breast Cancer
Lung Cancer
Melanoma Cancer
Colorectal Cancer
Prostate Cancer
Others
End-Use Outlook (Revenue, USD Million; 2019-2030)
Hospitals
Cancer Research Center
Diagnostic Labs
Browse Top Companies Data of This Report @ download Summary Of this Report
The report, additionally, offers a comprehensive SWOT analysis and Porter’s Five Forces analysis to offer a better understanding of the competitive landscape of the industry. It also covers strategies adopted by prominent players such as mergers and acquisitions, collaborations, joint ventures, product launches, and brand promotions, among others. The report aims to offer the readers a holistic understanding of the relevant features of the industry.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.